Loading clinical trials...
Loading clinical trials...
The purpose of this study is to examine whether co-administration of rifampin with neratinib has an effect on the pharmacokinetics (how the body absorbs, distributes, metabolizes and/or excretes) of n...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Puma Biotechnology, Inc.
NCT06342713 · Healthy Participants, Healthy Subjects, and more
NCT06014515 · Healthy Subjects, Cardiovascular Disease
NCT07181369 · Healthy Subjects, Cold Urticaria, and more
NCT07364149 · Healthy, Healthy Participants, and more
NCT07219940 · Healthy Subjects, Exosome, and more
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions